• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于卡铂持续释放的L-苏氨酸衍生的可生物降解聚氨酯纳米颗粒。

L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release.

作者信息

Oh Seoeun, Park Soo-Yong, Seo Hyung Il, Chung Ildoo

机构信息

Department of Polymer Science and Engineering, Pusan National University, Busan 46241, Republic of Korea.

Department of Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan 49241, Republic of Korea.

出版信息

Pharmaceutics. 2024 Dec 27;17(1):28. doi: 10.3390/pharmaceutics17010028.

DOI:10.3390/pharmaceutics17010028
PMID:39861677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769003/
Abstract

The use of polymeric nanoparticles (NPs) in drug delivery systems offers the advantages of enhancing drug efficacy and minimizing side effects; In this study, L-threonine polyurethane (LTPU) NPs have been fabricated by water-in-oil-in-water emulsion and solvent evaporation using biodegradable and biocompatible LTPU. This polymer was pre-synthesized through the use of an amino acid-based chain extender, desaminotyrosyl L-threonine hexyl ester (DLTHE), where urethane bonds are formed by poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) triblock copolymer and 1,6-hexamethylene diisocyanate (HDI). LTPU is designed to be degraded by hydrolysis and enzymatic activity due to the presence of ester bonds and peptide bonds within the polymer backbone. LTPU NPs were fabricated by water-in-oil-in-water double emulsion solvent evaporation methods; The polymerization of LTPU was confirmed by H-NMR, C-NMR, and FT-IR spectroscopies. The molecular weights and polydispersity, determined with GPC, were 28,800 g/mol and 1.46, respectively. The morphology and size of NPs, characterized by DLS, FE-SEM, TEM, and confocal microscopy, showed smooth and spherical particles with diameters less than 200 nm; In addition, the drug loading, encapsulation efficiency, and drug release profiles, using UV-Vis spectroscopy, showed the highest encapsulation efficiency with 2.5% carboplatin and sustained release profile.

摘要

在药物递送系统中使用聚合物纳米颗粒(NPs)具有提高药物疗效和最小化副作用的优点;在本研究中,通过水包油包水乳液和溶剂蒸发法,使用可生物降解且生物相容的L - 苏氨酸聚氨酯(LTPU)制备了LTPU NPs。该聚合物是通过使用基于氨基酸的扩链剂脱氨酪氨酸L - 苏氨酸己酯(DLTHE)预合成的,其中氨基甲酸酯键由聚(乳酸)-聚(乙二醇)-聚(乳酸)(PLA - PEG - PLA)三嵌段共聚物和1,6 - 六亚甲基二异氰酸酯(HDI)形成。由于聚合物主链中存在酯键和肽键,LTPU被设计为可通过水解和酶活性降解。LTPU NPs通过水包油包水双乳液溶剂蒸发法制备;通过H - NMR、C - NMR和FT - IR光谱确认了LTPU的聚合。用凝胶渗透色谱法测定的分子量和多分散性分别为28,800 g/mol和1.46。通过动态光散射(DLS)、场发射扫描电子显微镜(FE - SEM)、透射电子显微镜(TEM)和共聚焦显微镜表征的NPs的形态和尺寸显示,颗粒光滑且呈球形,直径小于200 nm;此外,使用紫外 - 可见光谱法测定的载药量、包封率和药物释放曲线显示,对于2.5%的卡铂,包封率最高且具有缓释曲线。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/ca8c81814631/pharmaceutics-17-00028-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/bb3520ac9c45/pharmaceutics-17-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/ffc46a34531a/pharmaceutics-17-00028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/601af884b12f/pharmaceutics-17-00028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/a7cf91fd1da6/pharmaceutics-17-00028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/c47da4922fb8/pharmaceutics-17-00028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/f09b694da52a/pharmaceutics-17-00028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/aabf92b95552/pharmaceutics-17-00028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/53ebbf48c44a/pharmaceutics-17-00028-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/a81a2e9fb61c/pharmaceutics-17-00028-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/92ce0b15d6f8/pharmaceutics-17-00028-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/ca8c81814631/pharmaceutics-17-00028-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/bb3520ac9c45/pharmaceutics-17-00028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/ffc46a34531a/pharmaceutics-17-00028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/601af884b12f/pharmaceutics-17-00028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/a7cf91fd1da6/pharmaceutics-17-00028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/c47da4922fb8/pharmaceutics-17-00028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/f09b694da52a/pharmaceutics-17-00028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/aabf92b95552/pharmaceutics-17-00028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/53ebbf48c44a/pharmaceutics-17-00028-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/a81a2e9fb61c/pharmaceutics-17-00028-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/92ce0b15d6f8/pharmaceutics-17-00028-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec6/11769003/ca8c81814631/pharmaceutics-17-00028-g011.jpg

相似文献

1
L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release.用于卡铂持续释放的L-苏氨酸衍生的可生物降解聚氨酯纳米颗粒。
Pharmaceutics. 2024 Dec 27;17(1):28. doi: 10.3390/pharmaceutics17010028.
2
Synthesis and Characterization of Polyfumarateurethane Nanoparticles for Sustained Release of Bupivacaine.用于布比卡因缓释的聚富马酸酯聚氨酯纳米颗粒的合成与表征
Pharmaceutics. 2020 Mar 21;12(3):281. doi: 10.3390/pharmaceutics12030281.
3
Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.载酮康唑的 PEG/PLA 纳米粒的抗真菌活性增强。
J Microencapsul. 2013;30(3):205-17. doi: 10.3109/02652048.2012.714410. Epub 2012 Aug 15.
4
Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.载罗丹明的聚乙二醇-聚乳酸纳米粒(NPs)的表征:聚乙二醇接枝密度的影响。
Int J Pharm. 2011 Jun 15;411(1-2):178-87. doi: 10.1016/j.ijpharm.2011.02.039. Epub 2011 Mar 31.
5
Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)-poly(ethylene glycol) for long-term sustained release.六臂共聚物聚己内酯-聚乙二醇的蛋白质递药纳米系统用于长效持续释放。
Int J Nanomedicine. 2018 May 8;13:2743-2754. doi: 10.2147/IJN.S161006. eCollection 2018.
6
Biodegradable PCL-b-PLA Microspheres with Nanopores Prepared via RAFT Polymerization and UV Photodegradation of Poly(Methyl Vinyl Ketone) Blocks.通过可逆加成-断裂链转移(RAFT)聚合和聚(甲基乙烯基酮)嵌段的紫外光降解制备的具有纳米孔的可生物降解聚己内酯-聚乳酸微球。
Polymers (Basel). 2021 Nov 16;13(22):3964. doi: 10.3390/polym13223964.
7
Synthesis, characterization and biocompatibility of biodegradable elastomeric poly(ether-ester urethane)s Based on Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) and Poly(ethylene glycol) via melting polymerization.基于聚(3-羟基丁酸酯-co-3-羟基己酸酯)和聚乙二醇通过熔融聚合制备可生物降解弹性体聚(醚-酯聚氨酯)的合成、表征及生物相容性
J Biomater Sci Polym Ed. 2009;20(9):1179-202. doi: 10.1163/156856209X452944.
8
Biodegradable poly(D,L-lactide-co-glycolide)/poly(L-γ-glutamic acid) nanoparticles conjugated to folic acid for targeted delivery of doxorubicin.叶酸偶联的可生物降解聚(D,L-丙交酯-共-乙交酯)/聚(L-γ-谷氨酸)纳米颗粒用于阿霉素的靶向递送
Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:743-751. doi: 10.1016/j.msec.2017.03.145. Epub 2017 Mar 18.
9
Dodecanol-poly(D,L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro.十二醇聚乳酸-聚(D,L-乳酸)-b-聚乙二醇-叶酸(Dol-PLA-PEG-FA)纳米粒:体外细胞毒性评价及选择能力。
Colloids Surf B Biointerfaces. 2013 Feb 1;102:130-5. doi: 10.1016/j.colsurfb.2012.07.030. Epub 2012 Jul 31.
10
Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.聚乙二醇(PEG)链结构对聚(D,L-丙交酯)(PLA)基纳米粒子理化性质的影响。
Eur J Pharm Biopharm. 2010 Jun;75(2):96-106. doi: 10.1016/j.ejpb.2010.03.002. Epub 2010 Mar 6.

本文引用的文献

1
Green Biodegradable Polylactide-Based Polyurethane Triblock Copolymers Reinforced with Cellulose Nanowhiskers.纤维素纳米晶须增强的绿色可生物降解聚丙交酯基聚氨酯三嵌段共聚物
J Funct Biomater. 2023 Feb 21;14(3):118. doi: 10.3390/jfb14030118.
2
Structural Optimization of Platinum Drugs to Improve the Drug-Loading and Antitumor Efficacy of PLGA Nanoparticles.铂类药物的结构优化以提高PLGA纳米颗粒的载药量和抗肿瘤疗效
Pharmaceutics. 2022 Oct 29;14(11):2333. doi: 10.3390/pharmaceutics14112333.
3
Fabrication and Biological Activities of Plasmid DNA Gene Carrier Nanoparticles Based on Biodegradable l-Tyrosine Polyurethane.
基于可生物降解的L-酪氨酸聚氨酯的质粒DNA基因载体纳米颗粒的制备及其生物活性
Pharmaceuticals (Basel). 2021 Dec 24;15(1):17. doi: 10.3390/ph15010017.
4
Polymeric Drug Delivery System with Actively Targeted Cell Penetration and Nuclear Targeting for Cancer Therapy.用于癌症治疗的具有主动靶向细胞穿透和核靶向功能的聚合物药物递送系统。
ACS Appl Bio Mater. 2019 Apr 15;2(4):1724-1731. doi: 10.1021/acsabm.9b00097. Epub 2019 Mar 21.
5
Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy.聚合物纳米载体用于癌症治疗的药物和基因靶向递送。
Int J Mol Sci. 2021 Aug 24;22(17):9118. doi: 10.3390/ijms22179118.
6
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.基于EPR效应的肿瘤靶向治疗癌症的最新进展
J Pers Med. 2021 Jun 18;11(6):571. doi: 10.3390/jpm11060571.
7
Polymer-based hydrogels with local drug release for cancer immunotherapy.基于聚合物的水凝胶具有局部药物释放功能,可用于癌症免疫治疗。
Biomed Pharmacother. 2021 May;137:111333. doi: 10.1016/j.biopha.2021.111333. Epub 2021 Feb 8.
8
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects.用于药物递送的聚合物纳米颗粒:最新进展与未来展望
Nanomaterials (Basel). 2020 Jul 19;10(7):1403. doi: 10.3390/nano10071403.
9
Recent advances in polymeric drug delivery systems.聚合物药物递送系统的最新进展。
Biomater Res. 2020 Jun 6;24:12. doi: 10.1186/s40824-020-00190-7. eCollection 2020.
10
Synthesis and Characterization of Polyfumarateurethane Nanoparticles for Sustained Release of Bupivacaine.用于布比卡因缓释的聚富马酸酯聚氨酯纳米颗粒的合成与表征
Pharmaceutics. 2020 Mar 21;12(3):281. doi: 10.3390/pharmaceutics12030281.